Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark S Sands

Showing results (71-80 of 105) with videos related to

Pageof 11
Sort By:
Blood|January 18, 2003
Neonatal or hepatocyte growth factor-potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia BLingfei Xu, Cuihua Gao, Mark S Sands, et al.
Plos One|August 23, 2007
Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type BCoy D Heldermon, Anne K Hennig, Kevin K Ohlemiller, et al.
Scientific Reports|July 5, 2022
Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizuresJoshua T Dearborn, Hemanth R Nelvagal, Nicholas R Rensing, et al.
Journal of Neuroscience Research|September 18, 2016
Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe's disease: Present convictions and future prospectsPeirong Hu, Yedda Li, Nana Nikolaishvili-Feinberg, et al.
Molecular Genetics and Metabolism|April 11, 2021
Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndromeShih-Hsin Kan, Ibrahim Elsharkawi, Steven Q Le, et al.
Human Gene Therapy|May 21, 2011
Lentiviral-mediated gene transfer to the sheep brain: implications for gene therapy in Batten diseaseKathryn S Linterman, David N Palmer, Graham W Kay, et al.
Journal of Inherited Metabolic Disease|June 11, 2026
Validating a Human Cell Model of Null Galactosylceramidase (GALC) Enzyme Activity That Recapitulates Krabbe DiseaseRodrigo T Starosta, Nazia Khatoon, Marie S Roberts, et al.
International Journal of Molecular Sciences|April 14, 2026
Systemic AAV9 Gene Therapy Mitigates Neuromuscular Junction Degeneration and Muscle Atrophy in a Mouse Model of CLN1 DiseaseEwa A Ziółkowska, Albina Jablonka-Shariff, Letitia L Williams, et al.
The Journal of Clinical Investigation|April 27, 2023
Gene therapy ameliorates spontaneous seizures associated with cortical neuron loss in a Cln2R207X mouse modelKeigo Takahashi, Elizabeth M Eultgen, Sophie H Wang, et al.
Molecular Genetics and Metabolism|June 21, 2025
Secondary accumulation of lyso-platelet activating factors in lysosomal storage diseasesPamela Kell, Sonali Mishra, Heather L Gray-Edwards, et al.
Pageof 11

Showing results (71-80 of 105) with videos related to

Sort By:
Pageof 11
Blood|January 18, 2003
Neonatal or hepatocyte growth factor-potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia BLingfei Xu, Cuihua Gao, Mark S Sands, et al.
Plos One|August 23, 2007
Development of sensory, motor and behavioral deficits in the murine model of Sanfilippo syndrome type BCoy D Heldermon, Anne K Hennig, Kevin K Ohlemiller, et al.
Scientific Reports|July 5, 2022
Effects of chronic cannabidiol in a mouse model of naturally occurring neuroinflammation, neurodegeneration, and spontaneous seizuresJoshua T Dearborn, Hemanth R Nelvagal, Nicholas R Rensing, et al.
Journal of Neuroscience Research|September 18, 2016
Hematopoietic Stem cell transplantation and lentiviral vector-based gene therapy for Krabbe's disease: Present convictions and future prospectsPeirong Hu, Yedda Li, Nana Nikolaishvili-Feinberg, et al.
Molecular Genetics and Metabolism|April 11, 2021
Biochemical evaluation of intracerebroventricular rhNAGLU-IGF2 enzyme replacement therapy in neonatal mice with Sanfilippo B syndromeShih-Hsin Kan, Ibrahim Elsharkawi, Steven Q Le, et al.
Human Gene Therapy|May 21, 2011
Lentiviral-mediated gene transfer to the sheep brain: implications for gene therapy in Batten diseaseKathryn S Linterman, David N Palmer, Graham W Kay, et al.
Journal of Inherited Metabolic Disease|June 11, 2026
Validating a Human Cell Model of Null Galactosylceramidase (GALC) Enzyme Activity That Recapitulates Krabbe DiseaseRodrigo T Starosta, Nazia Khatoon, Marie S Roberts, et al.
International Journal of Molecular Sciences|April 14, 2026
Systemic AAV9 Gene Therapy Mitigates Neuromuscular Junction Degeneration and Muscle Atrophy in a Mouse Model of CLN1 DiseaseEwa A Ziółkowska, Albina Jablonka-Shariff, Letitia L Williams, et al.
The Journal of Clinical Investigation|April 27, 2023
Gene therapy ameliorates spontaneous seizures associated with cortical neuron loss in a Cln2R207X mouse modelKeigo Takahashi, Elizabeth M Eultgen, Sophie H Wang, et al.
Molecular Genetics and Metabolism|June 21, 2025
Secondary accumulation of lyso-platelet activating factors in lysosomal storage diseasesPamela Kell, Sonali Mishra, Heather L Gray-Edwards, et al.
Pageof 11